HEIDELBERG PHARMA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 EUR | -1.98% |
|
-1.00% | -20.59% |
| 04-25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| 04-23 | Transcript : Heidelberg Pharma AG - Special Call |
Quotes 5-day view
Delayed Quote Xetra| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | |
|---|---|---|---|---|
| Last | 3.08 € | 3.04 € | 3.03 € | 2.97 € |
| Volume | 2 687 | 4 000 | 4 000 | 4 704 |
| Change | +2.67% | -1.30% | -0.33% | -1.98% |
| Opening | 3.11 | 3.05 | 3.03 | 3.03 |
| High | 3.12 | 3.05 | 3.03 | 3.04 |
| Low | 3.03 | 3.04 | 3.03 | 2.97 |
Performance
| 1 day | -1.98% | ||
| 1 week | -1.00% | ||
| Current month | -4.81% | ||
| 1 month | -4.81% | ||
| 3 months | -8.33% | ||
| 6 months | +7.61% | ||
| Current year | -20.59% | ||
| 1 year | -25.75% | ||
| 3 years | -60.92% | ||
| 5 years | -4.81% | ||
| 10 years | -8.49% |
Volumes
marketsDaily volume
4 704
Estimated daily volume
4 704
Avg. Volume 20 sessions
5 678
Daily volume ratio
0.83
Avg. Volume 20 sessions
16 863.66
Avg. Volume 20 sessions USD
18 071.60
Record volume 1
667 433
Record volume 2
496 625
Record volume 3
335 662
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
137 893 362
Capitalization (USD)
147 770 664
Net sales (EUR)
16 801 220
Net sales (USD)
18 004 691
Number of employees
95
Sales / Employee (EUR)
176 855
Sales / Employee (USD)
189 523
Free-Float
16.94 %
Free-Float capitalization (EUR)
23 363 476
Free-Float capitalization (USD)
25 037 002
Average Daily Capital Traded
0.01%
Highs and lows
1 week
2.97
3.12
1 month
2.963.14
Current year
2.873.73
1 year
2.634.09
3 years
2.638.68
5 years
2.009.70
10 years
1.399.70
Indicators
Moving average 5 days
3.02
Moving average 20 days
3.04
Moving average 50 days
3.06
Moving average 100 days
3.23
Price spread / (MMA5)
+1.82%
Price spread / (MMA20)
+2.34%
Price spread / (MMA50)
+2.86%
Price spread / (MMA100)
+8.89%
STIM
RSI 9 days
49.33
RSI 14 days
47.98
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.98% | -1.00% | -20.59% | -25.75% | 148M | ||
| -0.06% | +0.81% | -2.31% | +16.66% | 103B | ||
| -0.84% | -1.52% | +0.56% | +10.15% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.17% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -23.66% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.69% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.44% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.76% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +34.59% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +4.89% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.07% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +248.71% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +94.25% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +46.25% | 7.71B | ||
| +5.79% | +11.25% | -51.89% | -69.38% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +29.51% | 6.99B | ||
| Average | +1.46% | +3.72% | +10.19% | +14.15% | ||
| Weighted average by Cap. | +0.59% | +1.87% | +2.13% | +9.56% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
199.Ykq4B8SnTe8O4NMRBZfFFCnqZvKEUH76VOvAnkXjW6Y.NCWPapHfEqhKopl-MqePbnafDLz1BRWzZrH17T2mAcspD4BQhdU-12q2sA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 16:36:18 | 2.97 | 66 | 4,704 |
| 15:04:42 | 3.04 | 375 | 4,638 |
| 11:48:38 | 2.98 | 816 | 4,263 |
| 11:14:49 | 3 | 1,000 | 3,447 |
| 08:03:20 | 3 | 51 | 2,447 |
| 08:03:20 | 3.01 | 1,396 | 2,396 |
Monthly variations
Annual change
| 2024 | -20.59% | ||
| 2023 | -24.14% | ||
| 2022 | +3.68% | ||
| 2021 | -31.48% | ||
| 2020 | +228.91% | ||
| 2019 | -12.45% | ||
| 2018 | -25.82% | ||
| 2017 | +52.39% | ||
| 2016 | +35.21% | ||
| 2015 | -8.89% | ||
| 2014 | -66.69% | ||
| 2013 | +39.24% | ||
| 2012 | -72.02% | ||
| 2011 | -19.26% | ||
| 2010 | +18.36% | ||
| 2009 | +43.14% | ||
| 2008 | -62.61% | ||
| 2007 | -50.58% | ||
| 2006 | -0.22% |
- Stock Market
- Equities
- HPHA Stock
- Quotes Heidelberg Pharma AG
